Acorah Software Products - Accounts Production 16.3.350 false true false true No description of principal activity 28 June 2023 30 June 2024 30 June 2024 14966800 Dr Jansen Marnix iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14966800 2023-06-27 14966800 2024-06-30 14966800 2023-06-28 2024-06-30 14966800 frs-core:CurrentFinancialInstruments 2024-06-30 14966800 frs-bus:PrivateLimitedCompanyLtd 2023-06-28 2024-06-30 14966800 frs-bus:FilletedAccounts 2023-06-28 2024-06-30 14966800 frs-bus:Micro-entities 2023-06-28 2024-06-30 14966800 frs-bus:AuditExempt-NoAccountantsReport 2023-06-28 2024-06-30 14966800 frs-bus:Director1 2023-06-28 2024-06-30
Registered number: 14966800
Consensus Pathology Ltd
Unaudited Financial Statements
For The Year Ended 30 June 2024
Ballards Newman
Chartered Accountants
Apex House
Grand Arcade
North Finchley
London
N12 0EH
Balance Sheet
Registered number: 14966800
2024
£
Current assets 114,817
Creditors: Amounts Falling Due Within One Year (39,943 )
NET CURRENT ASSETS 74,874
TOTAL ASSETS LESS CURRENT LIABILITIES 74,874
Accruals and deferred income (1,200 )
NET ASSETS 73,674
CAPITAL AND RESERVES 73,674

Notes

1. General Information
Consensus Pathology Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14966800 . The registered office is 71-75 Shelton Street, Covent Garden, London, United Kingdom, WC2H 9JQ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Jansen Marnix
Director
15 June 2025